Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc. that provides Medactive exclusive rights to produce and market a new generation of oral care pharmaceuticals.
The agreement paves the way for introduction of Patient-Friendly's8482; Oral Care products, including Hi-Impact's8482; rinses, sprays, lozenges, gels, prophy tape, toothbrushes and
toothpastes.
Based on WhiteHill technology, property rights and trade secrets, the Patient-Friendly's8482; MedActive's174; Hi-Impact products will enable healthcare professionals to provide a new
standard of oral care to high-risk patients with serious oral complications associated with many health challenges.
Medactive expects to begin commercial introduction of the Patient-Friendly's8482; MedActive's174; HI-IMPACT's8482; Oral Care Products in the fourth quarter of this year. Additional
information is available on www.medactive.com
Patient-Friendly's8482; MedActive's174; products will be offered in single-use packaging - to protect against cross-contamination and to enhance patient compliance.
Medactive produces and markets OTC oral care products that provide relief of discomfort associated with Mucositis, Xerostomia (Dry Mouth), Oral Candidiasis (Thrush), Gingival
Inflammation, Stomatitis and other complications.
WhiteHill Oral Technologies, Inc. is a recognized leader in oral science and technologies and holds an impressive portfolio of property rights that have been licensed to major oral
healthcare marketers.
Statement by MedActive CEO Donald Mackey: Medactive is proud to have the opportunity to be associated with the well known and highly regarded team of oral care pioneers that is WhiteHill.
WhiteHill'ss well deserved reputation for absolute integrity comes with industry wide recognition for unwavering commitment to scientific excellence. Our ability to deliver 'sThe New
Standard for Oral Care's is now based on a rock solid strategic partnership.
Statement by WhiteHill CEO Dale Brown: :We believe this agreement will have a significant impact on the way oral care is provided to millions of needy people and we look forward to
working with Medactive to advance oral care. We recognize Medactive as a solid young company with a unique understanding of the importance of bringing highly effective oral care products
and protocols to medical healthcare. Medactive'ss commitment to improving compliance by providing samples of 'sPatient-Friendly's8482;'s products, free-of-charge, to high-risk patients,
through healthcare professionals, represents a major advance in oral care.
For Further Information Please Contact:
Medactive Media Group - Steve Papa
stevepapa @ medactive.com
866-887-4867
Fx: 888-441-7747
Medactive Oral Pharmaceuticals, LLC
8364 Forest Oaks Blvd.
Spring Hill, Fl. 34606
352-293-2164